News

Keith Yamamoto, PhD, vice chancellor for research at UC San Francisco, has been named to a national advisory group to guide research and clinical decisions about the use of genome editing technologies to treat human disease.

Matthew R. Cooperberg, MD, MPH, is the 2015 recipient of the American Urological Association (AUA) "Gold Cystoscope" award, given annually to one urologist who has made outstanding contributions to the profession within 10 years of completing residency training.

In a surprising finding, a team of UC San Francisco and Stanford University scientists has discovered that a protein thought to be crucial for the body to develop and function correctly can be reduced by half in mice with no apparent ill effects.

Men with an elevated, genetically inherited risk for prostate cancer could be routinely identified with a simple blood or urine test, scientists at UC San Francisco and Kaiser Permanente Northern California have concluded, potentially paving the way to better or earlier diagnosis.

Laura van 't Veer, co-leader of the HDFCCC Breast Oncology Program, and her team (Netherlands) was awarded the prize for the invention of a gene-based tissue test which makes it possible to offer targeted treatment for breast cancer.

A team of scientists from UC San Francisco and Mayo Clinic has shown that using just three molecular markers will help clinicians classify gliomas – the most common type of malignant brain tumors – more accurately than current methods.